Latest News

If you are wondering whether Main Street Capital is priced attractively right now, this article walks through its value case in a clear and practical way. The stock last closed at US$61.19, with a 1 year return of 13.9%, a 3 year return of 103.0% and a 5 year return of 177.4%. Shorter term moves include a 0.9% decline over the past week and a 2.8% decline over the past month. Recent attention on Main Street Capital has largely centered on its position as a listed business development company...

With Sanofi trading at €84.44, you might be wondering whether the current share price reflects a fair deal or if the market is mispricing the stock. Over the short term, the share price has moved, with a 2.6% return over the last 7 days, 2.1% over the last 30 days, and a 2.6% return year to date, alongside a 7.8% decline over the past year, 4.5% return over 3 years, and 26.2% over 5 years. These mixed returns sit against a backdrop of ongoing interest in large pharmaceutical groups like...

Ag Growth International (TSX:AFN) has released its Q3 2025 numbers, with revenue of CA$389.4 million and basic EPS of CA$0.83, alongside net income of CA$15.6 million. The company’s quarterly revenue has moved from CA$357.2 million and EPS of CA$0.94 in Q3 2024 to CA$389.4 million and EPS of CA$0.83 in Q3 2025, while trailing twelve month revenue sits at about CA$1.4 billion and EPS on this basis remains at a loss of CA$0.49. Overall, the results show solid top line scale, with margins that...

Howmet Aerospace (HWM) has caught investor attention recently, with the stock’s monthly return of 13.5% and past 3 months return of 18.6% inviting closer inspection of what might be driving sentiment. See our latest analysis for Howmet Aerospace. That recent momentum sits on top of a longer run where the share price return has been strong, with a 1 year total shareholder return of 94.29% and a very large 5 year total shareholder return. This suggests sentiment has shifted materially as...

In recent days, analysis of United Community Banks, Inc. highlighted that the regional lender has delivered only 4.1% annual revenue growth and 6.2% annual earnings per share growth over the past two years, lagging many banking peers. Forecasts pointing to relatively modest tangible book value per share growth and slower capital generation have raised questions about how effectively the bank is turning its expansion across the Southeast into shareholder value. Now we’ll examine how...

Geberit AG's ( VTX:GEBN ) price-to-earnings (or "P/E") ratio of 35.7x might make it look like a strong sell right now...

F5 (FFIV) is under close watch after disclosing a sophisticated nation state cyberattack that hit its BIG-IP product development environment, prompted revenue forecast revisions, and triggered multiple securities class action lawsuits questioning earlier disclosures. See our latest analysis for F5. F5's US$269.31 share price has seen a 4.94% 7 day share price return and a 4.35% 30 day share price return, while the 1 year total shareholder return of 5.89% contrasts with a much stronger 3 year...

SmartStop Self Storage REIT (SMA) has been drawing attention after recent trading, with the stock last closing at $32.22. Short term returns are mixed, which has some investors revisiting fundamentals and valuation. See our latest analysis for SmartStop Self Storage REIT. That recent 1-day share price return of 1.77% and 7-day share price return of 4.75% sit against a year to date share price return of 4.75%, while the 90-day share price return of 7.71% indicates that momentum has been fading...

In early January 2026, Harmony Biosciences Holdings drew renewed attention as it advanced clinical programs for WAKIX and other rare neurological disease candidates while preparing for a company presentation at the J.P. Morgan Healthcare Conference. This combination of an expanding pipeline, solid reported profitability, and predominantly positive analyst sentiment has sharpened investor focus on the company’s long-term prospects. Now we’ll examine how Harmony’s progress with WAKIX and its...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Adcorp...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Atlas Copco's (STO:ATCO A) stock is up by 8.3% over the past three months. Given that the market rewards strong...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

While Eckert & Ziegler SE ( ETR:EUZ ) might not have the largest market cap around , it saw a decent share price growth...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Despite an already strong run, Viridien Société anonyme ( EPA:VIRI ) shares have been powering on, with a gain of 26...

Key Insights Institutions' substantial holdings in Nobia implies that they have significant influence over the...

To avoid investing in a business that's in decline, there's a few financial metrics that can provide early indications...

If you are wondering whether Chubb's current share price lines up with its underlying value, you are not alone, and that is exactly what this article will help you unpack. Chubb shares last closed at US$306.81, with returns of a 1% decline over the past week, 3.5% over the past month, a 1% decline year to date, 20.6% over the past year, 41% over three years, and 113.6% over five years, which can influence how investors think about both growth potential and risk today. Recent headlines around...

In early January 2026, RBC reiterated its positive view on Trisura Group after December 2025 excess and surplus insurance stamping office data from California, Florida, and Texas showed a strong pickup in sector premiums. This sector-level acceleration in key U.S. specialty markets is being interpreted as a supportive signal for Trisura’s opportunity set in excess and surplus lines. We’ll now examine how the strengthening excess and surplus premium trends could influence Trisura Group’s...

Mirum Pharmaceuticals (MIRM) has drawn attention after initiating the BLOOM Phase 2 trial of MRM-3379 in Fragile X syndrome, alongside fresh institutional interest and recent revenue growth that some investors interpret as a sign of business momentum. See our latest analysis for Mirum Pharmaceuticals. The recent 6.09% 1 day share price return and 33.86% 30 day share price return, taking Mirum to $86.57, line up with the Phase 2 trial news, institutional buying and revenue growth. At the same...

L'Air Liquide (ENXTPA:AI) is back in the spotlight as investors focus on its ADVANCE 2025 plan, particularly large projects tied to energy transition, low carbon hydrogen, and decarbonization across industrial, healthcare, and electronics markets. See our latest analysis for L'Air Liquide. L'Air Liquide's share price has recently been more muted, with a 6.37% decline over the past 90 days. However, the 1 year total shareholder return of 3.57% and 5 year total shareholder return of 58.95%...

In early January 2026, Raymond James downgraded MPLX from Outperform to Market Perform, following JP Morgan’s earlier move to lower its rating as analysts flagged limited organic growth prospects and a heavier reliance on mergers and acquisitions. At the same time, MPLX reported higher quarterly revenue and net profit than a year earlier and scheduled a February 3, 2026 earnings call, setting up a contrast between improving recent results and more cautious views on its longer-term growth...